Please use this identifier to cite or link to this item: http://www.repositorio.ufop.br/handle/123456789/7864
Title: Hypotensive effect of Ang II and Ang-(1-7) at the caudal ventrolateral medulla involves different mechanisms.
Authors: Alzamora, Andréia Carvalho
Santos, Robson Augusto Souza dos
Santos, Maria José Campagnole dos
Keywords: Angiotensin
Arterial pressure
Nitric oxide
Sympathetic nervous system
Issue Date: 2002
Citation: ALZAMORA, A. C.; SANTOS, R. A. S.; SANTOS, M. J. C. Hypotensive effect of Ang II and Ang-(1-7) at the caudal ventrolateral medulla involves different mechanisms. Regulatory, Integrative and Comparative Physiology, v. 283, p. R1187-R1195, 2002. Disponível em: <http://ajpregu.physiology.org/content/283/5/R1187>. Acesso em: 19 fev. 2017.
Abstract: Hypotensive effect of ANG II and ANG-(1–7) at the caudal ventrolateral medulla involves different mechanisms. Am J Physiol Regul Integr Comp Physiol 283: R1187–R1195, 2002. First published July 18, 2002; 10.1152/ ajpregu.00580.2001.—The objective of the present study was to determine the contribution of the autonomic nervous system and nitric oxide to the depressor effect produced by unilateral microinjection of ANG-(1–7) and ANG II into the caudal ventrolateral medulla (CVLM). Unilateral microinjection of ANG-(1–7), ANG II (40 pmol), or saline (100 nl) was made into the CVLM of male Wistar rats anesthetized with urethane before and after intravenous injection of 1) methylatropine, 2.5 mg/kg; 2) prazosin, 25 g/kg; 3) the nitric oxide synthase (NOS) inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), 5 mg/kg; or 4) the specific inhibitor of neuronal NOS, 7-nitroindazole (7-NI), 45 mg/kg. Arterial pressure and heart rate (HR) were continuously monitored. Microinjection of ANG-(1–7) or ANG II into the CVLM produced a significant decrease in mean arterial pressure (MAP; 11 1 mmHg, n 12 and 10 1 mmHg, n 10, respectively) that was not accompanied by consistent changes in HR or in cardiac output. The effect of ANG-(1–7) was abolished after treatment with methyl-atropine ( 3 0.6 mmHg, n 9) or L-NAME ( 2.3 0.5 mmHg, n 8) or 7-NI ( 2.8 0.6 mmHg, n 5). In contrast, these treatments did not significantly interfere with the ANG II effect ( 10 2.6 mmHg, n 8; 8 1.5 mmHg, n 8; and 12 3.6 mmHg, n 6; respectively). Peripheral treatment with prazosin abolished the hypotensive effect of ANG-(1–7) and ANG II. Microinjection of saline did not produce any significant change in MAP or in HR. These results suggest that the hypotensive effect produced by ANG II at the CVLM depends on changes in adrenergic vascular tonus and, more importantly, the hypotensive effect produced by ANG-(1–7) also involves a nitric oxide-related mechanism.
URI: http://www.repositorio.ufop.br/handle/123456789/7864
metadata.dc.identifier.uri2: http://ajpregu.physiology.org/content/283/5/R1187
ISSN: 15221490
Appears in Collections:DECBI - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_HypotensiveEffectANGII.pdf170,37 kBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.